Korte Keppestraat 21
Aalst 9320
Belgium
32 5 333 36 00
https://ontex.com
Settore/i: Consumer Defensive
Settore: Household & Personal Products
Impiegati a tempo pieno: 7.500
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Gustavo Calvo Paz | CEO and Interim CFO | 222,67k | N/D | 1962 |
Mr. Jonas Deroo | Chief HR & Legal Officer and Sec. Gen. | N/D | N/D | N/D |
Ms. Annick De Poorter | Chief Innovation & Sustainability Officer and Exec. VP of Quality | N/D | N/D | 1971 |
Mr. Laurent Nielly | Pres of the Europe Division | N/D | N/D | N/D |
Mr. Geoffroy Raskin | VP of Investor Relations & Financial Communication | N/D | N/D | N/D |
Mr. Luc Missorten | Sr. Advisor to the Board | N/D | N/D | 1955 |
Mr. Paul R. Wood | Pres North America | N/D | N/D | 1973 |
Ontex Group NV develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally. It offers baby care products, such as baby diapers and pants, and wet wipes under the Baby Pants, Bbtips, Bio Baby, Chicolastics Classic, Canbebe, Helen Harper, Kiddies, Little Big Change, Moltex, Pom Pom, Sapeka, and Mônica brands; and feminine care products, including sanitary towels, panty liners, and tampons under the Fiore, Mia, NAT, Sincere, and Silhouette brand names. The company also provides adult incontinence products comprising adult pants and diapers, incontinence towels, and bed protection products under the A Lovely Day, Adultmax Maturidade, Affective, Bigfral, iD, Canped, Liberty, Lille Healthcare, Kylie, Serenity, Orizon, and Moviment brands,as well as sells face masks. It sells its products to consumers, retailers, and institutional and private healthcare providers, as well as offers products under retailer brands. Ontex Group NV was founded in 1979 and is headquartered in Aalst, Belgium. Ontex Group NV operates as a subsidiary of Groupe Bruxelles Lambert SA.
L'ISS Governance QualityScore di Ontex Group NV al 1 ottobre 2023 è 5. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 3; diritti degli azionisti: 1; retribuzione: 8.